Literature DB >> 33872107

Primary Biphasic Hepatic Sarcoma in DICER1 Syndrome.

Sharlene C See1, Nitin R Wadhwani2, Kai Lee Yap2, Nicoleta C Arva2.   

Abstract

DICER1 tumor predisposition syndrome is a rare genetic disorder that predisposes individuals to multiple benign and malignant neoplasms. The phenotype is vast and includes pleuropulmonary blastoma (PPB), thyroid nodules, cystic nephroma, Wilms tumor, ovarian Sertoli-Leydig cell tumor, and medulloepithelioma, among others. Herein, we describe a patient with a DICER1 germline pathogenic variant presenting with two neoplasms that are not commonly encountered in the context of DICER1 syndrome. The first tumor is a multiloculated cystic hepatic lesion with a biphasic pattern, composed of cysts lined by bland biliary type (CK19-positive) epithelium surrounded by a condensation of sarcomatous spindled cell proliferation in a myxoid stroma. This neoplasm resembled PPB or cystic nephroma with malignant transformation. The second tumor is a chest nodule consistent with low-grade hidradenocarcinoma. Although it is difficult to speculate with just a single case, these unusual neoplasms occurring in particular at a young age raises the possibility that they can be inherent to, and thus, be part of the DICER1 tumor predisposition syndrome phenotype.

Entities:  

Keywords:  DICER1; hepatic cyst; hidradenocarcinoma; hidradenoma; phenotype

Mesh:

Substances:

Year:  2021        PMID: 33872107     DOI: 10.1177/10935266211008443

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  2 in total

1.  DICER1-associated hepatic cystic neoplasm with pleuropulmonary blastoma-like features: a novel clinicopathologic diagnosis.

Authors:  Sarah G Mitchell; Kris Ann P Schultz; Heather Rytting; Nicolas Kostelecky; D Ashley Hill; Louis P Dehner
Journal:  Mod Pathol       Date:  2021-12-14       Impact factor: 8.209

Review 2.  DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma.

Authors:  Iván A González; Douglas R Stewart; Kris Ann P Schultz; Amanda P Field; D Ashley Hill; Louis P Dehner
Journal:  Mod Pathol       Date:  2021-10-01       Impact factor: 7.842

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.